Mendor Inks $11.6M in Series B
Helsinki-based healthcare company Mendor has closed on 8.1 million euros ($11.64 million) in Series B financing from Finnish entrepreneur and investor Risto Siilasmaa, Life Sciences Partners, Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and Finnvera Venture Capital. The company, formed in 2006, develops diabetes technologies and services.
22 June 2011•4 mins read
